Article

FDG-PET Useful to Resolve Doubts About GCA

A systematic review finds the technique highly sensitive and specific in diagnosing giant cell arteritis, especially useful when biopsy results are equivocal.

Soussan M, Nicolas P, Schramm C, et al. Management of Large-Vessel Vasculitis With FDG-PET: A Systematic Literature Review and Meta-Analysis.Medicine. 2015;94(14)e622. doi: 10.1097/MD.0000000000000622

18F-fluorodeoxyglucose positron emission tomography (FDG-PET) has high sensitivity and specificity for diagnosing large-vessel inflammation in giant cell arteritis (GCA). This could be useful where GCA is still suspected after a negative temporal artery biopsy.

The sensitivity and specificity for Takayasu arteritis (TA) is almost as good.

This was the result of a systematic review of 21 studies with 413 patients and 299 controls. Inflammatory cells such as macrophages or granulation tissue avidly take up FDG. FDG-PET showed FDG vascular uptake in 70% of patients and 7%ofcontrols. Only vascular uptake equal to or higher than the liver uptake was significantly different between GCA or TA patients and controls.

For GCA, the sensitivity was 90% and the specificity was 98%. For TA, the sensitivity was 87% and specificity was 73%.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.